Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial
Open Access
- 7 January 2014
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 13 (1) , 9
Abstract
The efficacy of artemisinin-based combination therapy (ACT) has been established. The objective of the present study was to compare the efficacy and safety in the Central African Republic (CAR) of three commercially available artemisinin-based combinations, artemether + lumefantrine (AL), artesunate + sulphamethoxypyrazine-pyrimethamine (AS-SMP) and artesunate + amodiaquine (AS-AQ), with those of sulphadoxine-pyrimethamine + amodiaquine (SP-AQ), which was the first-line reference treatment in the country from 2004, until it was replaced by ACT in 2006 in accordance with changes in international recommendations based on resistance identified in other regions .Keywords
This publication has 31 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trialMalaria Journal, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West AfricaMalaria Journal, 2007
- Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern TanzaniaMalaria Journal, 2007
- A randomized, placebo‐controlled, double‐blind trial on sulfadoxine–pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malariaTropical Medicine & International Health, 2005
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Clinical Pharmacokinetics and Pharmacodynamics of Artemether-LumefantrineClinical Pharmacokinetics, 1999
- Population pharmacokinetics and therapeutic response of CGP 56697 (artemether+benflumetol) in malaria patientsBritish Journal of Clinical Pharmacology, 1998
- Amodiaquine-induced fulminant hepatitisJournal of Hepatology, 1988